BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Milford DV, Taylor CM, Guttridge B, Hall SM, Rowe B, Kleanthous H. Haemolytic uraemic syndromes in the British Isles 1985-8: association with verocytotoxin producing Escherichia coli. Part 1: Clinical and epidemiological aspects. Arch Dis Child 1990;65:716-21. [PMID: 2201261 DOI: 10.1136/adc.65.7.716] [Cited by in Crossref: 115] [Cited by in F6Publishing: 108] [Article Influence: 3.6] [Reference Citation Analysis]
Number Citing Articles
1 Brigotti M, Carnicelli D, Arfilli V, Tamassia N, Borsetti F, Fabbri E, Tazzari PL, Ricci F, Pagliaro P, Spisni E, Cassatella MA. Identification of TLR4 as the Receptor That Recognizes Shiga Toxins in Human Neutrophils. J I 2013;191:4748-58. [DOI: 10.4049/jimmunol.1300122] [Cited by in Crossref: 57] [Cited by in F6Publishing: 56] [Article Influence: 6.3] [Reference Citation Analysis]
2 Robson WL, Leung AK, Kaplan BS. Hemolytic-uremic syndrome. Curr Probl Pediatr 1993;23:16-33. [PMID: 8453889 DOI: 10.1016/0045-9380(93)90027-a] [Cited by in Crossref: 28] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
3 Taylor C. Verocytotoxin-producing Escherichia coli and the haemolytic uraemic syndrome. Journal of Infection 1995;30:189-92. [DOI: 10.1016/s0163-4453(95)90601-0] [Cited by in Crossref: 10] [Article Influence: 0.4] [Reference Citation Analysis]
4 Gracey M. Transmission and epidemiology. Baillière's Clinical Gastroenterology 1993;7:195-214. [DOI: 10.1016/0950-3528(93)90040-y] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
5 Harwood R, Wilkinson D, Ramkumar S, Humphrey G. Gram-negative organisms in peritoneal dialysis peritonitis: an early indication for surgery in patients with haemolytic uraemic syndrome? Pediatr Surg Int 2016;32:235-8. [PMID: 26578260 DOI: 10.1007/s00383-015-3833-6] [Reference Citation Analysis]
6 Hirao I, Madin K, Endo Y, Yokoyama S, Ellington AD. RNA Aptamers That Bind to and Inhibit the Ribosome-inactivating Protein, Pepocin. Journal of Biological Chemistry 2000;275:4943-8. [DOI: 10.1074/jbc.275.7.4943] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.0] [Reference Citation Analysis]
7 Elliott EJ, Robins-Browne RM. Hemolytic uremic syndrome. Curr Probl Pediatr Adolesc Health Care 2005;35:310-30. [PMID: 16126151 DOI: 10.1016/j.cppeds.2005.06.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
8 Skakauskas V, Katauskis P. Modeling neutralization of Shiga 2 toxin by A-and B-subunit-specific human monoclonal antibodies. J Biol Phys 2016;42:435-52. [PMID: 27155978 DOI: 10.1007/s10867-016-9416-5] [Reference Citation Analysis]
9 Carnicelli D, Arfilli V, Ricci F, Velati C, Tazzari PL, Brigotti M. The Antibiotic Polymyxin B Impairs the Interactions between Shiga Toxins and Human Neutrophils. J I 2016;196:1177-85. [DOI: 10.4049/jimmunol.1500671] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
10 Johnson S, Waters A. Is complement a culprit in infection-induced forms of haemolytic uraemic syndrome? Immunobiology 2012;217:235-43. [PMID: 21852019 DOI: 10.1016/j.imbio.2011.07.022] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
11 Chart H, Jenkins C. The serodiagnosis of infections caused by Verocytotoxin‐producing Escherichia coli. Journal of Applied Microbiology 2001;86:731-40. [DOI: 10.1046/j.1365-2672.1999.00766.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 1.4] [Reference Citation Analysis]
12 Fujii J, Kinoshita Y, Kita T, Higure A, Takeda T, Tanaka N, Yoshida S. Magnetic resonance imaging and histopathological study of brain lesions in rabbits given intravenous verotoxin 2. Infect Immun 1996;64:5053-60. [DOI: 10.1128/iai.64.12.5053-5060.1996] [Cited by in Crossref: 48] [Cited by in F6Publishing: 28] [Article Influence: 1.8] [Reference Citation Analysis]
13 O’brien AD, Tesh VL, Donohue-rolfe A, Jackson MP, Olsnes S, Sandvig K, Lindberg AA, Keusch GT. Shiga Toxin: Biochemistry, Genetics, Mode of Action, and Role in Pathogenesis. In: Sansonetti PJ, editor. Pathogenesis of Shigellosis. Berlin: Springer Berlin Heidelberg; 1992. pp. 65-94. [DOI: 10.1007/978-3-642-77238-2_4] [Cited by in Crossref: 62] [Cited by in F6Publishing: 137] [Article Influence: 2.1] [Reference Citation Analysis]
14 Krautz-Peterson G, Chapman-Bonofiglio S, Boisvert K, Feng H, Herman IM, Tzipori S, Sheoran AS. Intracellular neutralization of shiga toxin 2 by an a subunit-specific human monoclonal antibody. Infect Immun 2008;76:1931-9. [PMID: 18285498 DOI: 10.1128/IAI.01282-07] [Cited by in Crossref: 34] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
15 Thomas A, Chart H, Cheasty T, Smith HR, Frost JA, Rowe B. Vero cytotoxin-producing Escherichia coli, particularly serogroup O 157, associated with human infections in the United Kingdom: 1989-91. Epidemiol Infect 1993;110:591-600. [PMID: 8519324 DOI: 10.1017/s0950268800051013] [Cited by in Crossref: 63] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
16 Mark Taylor C. Enterohaemorrhagic Escherichia coli and Shigella dysenteriae type 1-induced haemolytic uraemic syndrome. Pediatr Nephrol 2008;23:1425-31. [PMID: 18493800 DOI: 10.1007/s00467-008-0820-3] [Cited by in Crossref: 41] [Cited by in F6Publishing: 30] [Article Influence: 2.9] [Reference Citation Analysis]
17 Lynn RM, O'Brien SJ, Taylor CM, Adak GK, Chart H, Cheasty T, Coia JE, Gillespie IA, Locking ME, Reilly WJ, Smith HR, Waters A, Willshaw GA. Childhood hemolytic uremic syndrome, United Kingdom and Ireland. Emerg Infect Dis 2005;11:590-6. [PMID: 15829199 DOI: 10.3201/eid1104.040833] [Cited by in Crossref: 109] [Cited by in F6Publishing: 95] [Article Influence: 6.4] [Reference Citation Analysis]
18 Chart H. Serodiagnosis of infections caused by Escherichia coli O157:H7 and other VTEC. Serodiagnosis and Immunotherapy in Infectious Disease 1993;5:8-12. [DOI: 10.1016/0888-0786(93)90017-t] [Cited by in Crossref: 5] [Article Influence: 0.2] [Reference Citation Analysis]
19 Johnson S, Taylor CM. Hemolytic Uremic Syndrome. In: Avner E, Harmon W, Niaudet P, Yoshikawa N, editors. Pediatric Nephrology. Berlin: Springer Berlin Heidelberg; 2009. pp. 1155-80. [DOI: 10.1007/978-3-540-76341-3_48] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
20 Acheson DW, Keusch GT. The shigella paradigm and colitis due to enterohaemorrhagic Escherichia coli. Gut 1994;35:872-4. [PMID: 8063211 DOI: 10.1136/gut.35.7.872] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
21 Nagai T, Hasegawa O, Tuji A, Kamiyama Y, Honda M, Ito H. Pituitary hemorrhage in hemolytic uremic syndrome. Pediatric Neurology 1992;8:75-6. [DOI: 10.1016/0887-8994(92)90059-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
22 Jeong KI, Chapman-Bonofiglio S, Singh P, Lee J, Tzipori S, Sheoran AS. In vitro and in vivo protective efficacies of antibodies that neutralize the RNA N-glycosidase activity of Shiga toxin 2. BMC Immunol 2010;11:16. [PMID: 20334660 DOI: 10.1186/1471-2172-11-16] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
23 Brook MG, Bannister BA. Verocytotoxin producing Escherichia coli. BMJ 1991;303:800-1. [PMID: 1932966 DOI: 10.1136/bmj.303.6806.800] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
24 Karpac CA, Li X, Terrell DR, Kremer Hovinga JA, Lämmle B, Vesely SK, George JN. Sporadic bloody diarrhoea-associated thrombotic thrombocytopenic purpura-haemolytic uraemic syndrome: an adult and paediatric comparison. Br J Haematol 2008;141:696-707. [DOI: 10.1111/j.1365-2141.2008.07116.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 33] [Article Influence: 3.0] [Reference Citation Analysis]
25 Cleary TG. ESCHERICHIA COEI THAT CAUSE HEMOLYTIC UREMIC SYNDROME. Infectious Disease Clinics of North America 1992;6:163-76. [DOI: 10.1016/s0891-5520(20)30431-1] [Cited by in Crossref: 11] [Article Influence: 0.4] [Reference Citation Analysis]
26 King AJ. Acute inflammation in the pathogenesis of hemolytic-uremic syndrome. Kidney International 2002;61:1553-64. [DOI: 10.1046/j.1523-1755.2002.00281.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
27 Cornu G, Proesmans W, Dediste A, Jacobs F, Van De Walle J, Mertens A, Ramet J, Lauwers S. Hemolytic uremic syndrome in Belgium: incidence and association with verocytotoxin-producing Escherichia coli infection. Clin Microbiol Infect 1999;5:16-22. [PMID: 11856208 DOI: 10.1111/j.1469-0691.1999.tb00093.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 20] [Article Influence: 0.7] [Reference Citation Analysis]
28 Besbas N, Karpman D, Landau D, Loirat C, Proesmans W, Remuzzi G, Rizzoni G, Taylor CM, Van de Kar N, Zimmerhackl LB; European Paediatric Research Group for HUS. A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders. Kidney Int 2006;70:423-31. [PMID: 16775594 DOI: 10.1038/sj.ki.5001581] [Cited by in Crossref: 199] [Cited by in F6Publishing: 144] [Article Influence: 12.4] [Reference Citation Analysis]
29 George JN, Sadler JE, Lämmle B. Platelets: Thrombotic Thrombocytopenic Purpura. Hematology 2002;2002:315-34. [DOI: 10.1182/asheducation-2002.1.315] [Cited by in Crossref: 45] [Cited by in F6Publishing: 36] [Article Influence: 2.3] [Reference Citation Analysis]
30 Cimolai N, Carter JE. Gender and the progression of Escherichia coli O157:H7 enteritis to haemolytic uraemic syndrome. Arch Dis Child 1991;66:171-2. [PMID: 1994852 DOI: 10.1136/adc.66.1.171-c] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
31 Byrne L, Jenkins C, Launders N, Elson R, Adak GK. The epidemiology, microbiology and clinical impact of Shiga toxin-producing Escherichia coli in England, 2009-2012. Epidemiol Infect 2015;143:3475-87. [PMID: 25920912 DOI: 10.1017/S0950268815000746] [Cited by in Crossref: 81] [Cited by in F6Publishing: 44] [Article Influence: 11.6] [Reference Citation Analysis]
32 Armon K, Stephenson T, MacFaul R, Eccleston P, Werneke U. An evidence and consensus based guideline for acute diarrhoea management. Arch Dis Child 2001;85:132-42. [PMID: 11466188 DOI: 10.1136/adc.85.2.132] [Cited by in Crossref: 99] [Cited by in F6Publishing: 65] [Article Influence: 4.7] [Reference Citation Analysis]
33 Oliver JW, Akins RS, Bibens MK, Dunn DM. Pneumococcal Induced T-activation with Resultant Thrombotic Microangiopathy. Clin Med Insights Pathol 2010;3:13-7. [PMID: 21151550 DOI: 10.4137/cpath.s670] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
34 Cochran JB, Panzarino VM, Maes LY, Tecklenburg FW. Pneumococcus-induced T-antigen activation in hemolytic uremic syndrome and anemia. Pediatr Nephrol 2004;19:317-21. [PMID: 14714171 DOI: 10.1007/s00467-003-1382-z] [Cited by in Crossref: 56] [Cited by in F6Publishing: 43] [Article Influence: 3.1] [Reference Citation Analysis]
35 Paton JC, Paton AW. Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections. Clin Microbiol Rev 1998;11:450-79. [PMID: 9665978 DOI: 10.1128/CMR.11.3.450] [Cited by in Crossref: 936] [Cited by in F6Publishing: 357] [Article Influence: 39.0] [Reference Citation Analysis]
36 Flagler MJ, Strasser JE, Chalk CL, Weiss AA. Comparative analysis of the abilities of Shiga toxins 1 and 2 to bind to and influence neutrophil apoptosis. Infect Immun 2007;75:760-5. [PMID: 17101648 DOI: 10.1128/IAI.01594-06] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
37 Taylor CM, Monnens LA. Advances in haemolytic uraemic syndrome. Arch Dis Child 1998;78:190-3. [PMID: 9579168 DOI: 10.1136/adc.78.2.190] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.5] [Reference Citation Analysis]
38 Waters AM, Kerecuk L, Luk D, Haq MR, Fitzpatrick MM, Gilbert RD, Inward C, Jones C, Pichon B, Reid C, Slack MP, Van't Hoff W, Dillon MJ, Taylor CM, Tullus K. Hemolytic uremic syndrome associated with invasive pneumococcal disease: the United kingdom experience. J Pediatr 2007;151:140-4. [PMID: 17643764 DOI: 10.1016/j.jpeds.2007.03.055] [Cited by in Crossref: 110] [Cited by in F6Publishing: 80] [Article Influence: 7.3] [Reference Citation Analysis]
39 Chouillet A, Maguire H, Kurtz Z. Policies for control of communicable disease in day care centres. Arch Dis Child 1992;67:1103-6. [PMID: 1417054 DOI: 10.1136/adc.67.9.1103] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
40 Mele C, Remuzzi G, Noris M. Hemolytic uremic syndrome. Semin Immunopathol 2014;36:399-420. [PMID: 24526222 DOI: 10.1007/s00281-014-0416-x] [Cited by in Crossref: 92] [Cited by in F6Publishing: 67] [Article Influence: 11.5] [Reference Citation Analysis]
41 Michael M, Elliott EJ, Ridley GF, Hodson EM, Craig JC. Interventions for haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura. Cochrane Database Syst Rev 2009;:CD003595. [PMID: 19160220 DOI: 10.1002/14651858.CD003595.pub2] [Cited by in Crossref: 34] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
42 Neuhaus TJ, Calonder S, Leumann EP. Heterogeneity of atypical haemolytic uraemic syndromes. Arch Dis Childhood. 1997;76:518-521. [PMID: 9245850 DOI: 10.1136/adc.76.6.518] [Cited by in Crossref: 52] [Cited by in F6Publishing: 39] [Article Influence: 2.1] [Reference Citation Analysis]
43 Elliott EJ, Robins-Browne RM, O'Loughlin EV, Bennett-Wood V, Bourke J, Henning P, Hogg GG, Knight J, Powell H, Redmond D; Contributors to the Australian Paediatric Surveillance Unit. Nationwide study of haemolytic uraemic syndrome: clinical, microbiological, and epidemiological features. Arch Dis Child 2001;85:125-31. [PMID: 11466187 DOI: 10.1136/adc.85.2.125] [Cited by in Crossref: 142] [Cited by in F6Publishing: 117] [Article Influence: 6.8] [Reference Citation Analysis]
44 Milford DV, Taylor CM. New insights into the haemolytic uraemic syndromes. Arch Dis Child 1990;65:713-5. [PMID: 2201260 DOI: 10.1136/adc.65.7.713] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 0.8] [Reference Citation Analysis]
45 Fujii J, Kita T, Yoshida S, Takeda T, Kobayashi H, Tanaka N, Ohsato K, Mizuguchi Y. Direct evidence of neuron impairment by oral infection with verotoxin-producing Escherichia coli O157:H- in mitomycin-treated mice. Infect Immun 1994;62:3447-53. [PMID: 8039916 DOI: 10.1128/iai.62.8.3447-3453.1994] [Cited by in Crossref: 88] [Cited by in F6Publishing: 41] [Article Influence: 3.1] [Reference Citation Analysis]
46 Fitzpatrick MM, Shah V, Trompeter RS, Dillon MJ, Barratt TM. Long term renal outcome of childhood haemolytic uraemic syndrome. BMJ 1991;303:489-92. [PMID: 1912857 DOI: 10.1136/bmj.303.6801.489] [Cited by in Crossref: 58] [Cited by in F6Publishing: 46] [Article Influence: 1.9] [Reference Citation Analysis]
47 Sheoran A, Jeong KI, Mukherjee J, Wiffin A, Singh P, Tzipori S. Biodistribution and elimination kinetics of systemic Stx2 by the Stx2A and Stx2B subunit-specific human monoclonal antibodies in mice. BMC Immunol 2012;13:27. [PMID: 22655967 DOI: 10.1186/1471-2172-13-27] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
48 Birk PE, Chakrabarti S, Lacson AG, Ogborn MR. Cardiac tamponade as a terminal event in the hemolytic uremic syndrome in childhood. Pediatr Nephrol 1994;8:754-5. [PMID: 7696120 DOI: 10.1007/BF00869112] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
49 Ariceta G, Besbas N, Johnson S, Karpman D, Landau D, Licht C, Loirat C, Pecoraro C, Taylor CM, Van de Kar N, Vandewalle J, Zimmerhackl LB; European Paediatric Study Group for HUS. Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome. Pediatr Nephrol 2009;24:687-96. [PMID: 18800230 DOI: 10.1007/s00467-008-0964-1] [Cited by in Crossref: 225] [Cited by in F6Publishing: 173] [Article Influence: 16.1] [Reference Citation Analysis]
50 Gracey M. Bacterial diarrhoea. Annals of Tropical Paediatrics 2016;13:107-19. [DOI: 10.1080/02724936.1993.11747635] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
51 Mariani-kurkdjian P, Lambert-zechovsky N. Escherichia coli et syndrome hémolytique et urémique. Médecine et Maladies Infectieuses 1991;21:567-70. [DOI: 10.1016/s0399-077x(05)81177-1] [Reference Citation Analysis]
52 Takeda T, Nakao H, Yamanaka T, Igarashi T, Takeda Y, Kobayashi N. High prevalence of serum antibodies to Verotoxins 1 and 2 among healthy adults in Japan. Journal of Infection 1993;27:211-3. [DOI: 10.1016/0163-4453(93)95079-x] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
53 Fizpatrick MM, Walters MD, Trompeter RS, Dillon MJ, Barratt TM. Atypical (non-diarrhea-associated) hemolytic-uremic syndrome in childhood. The Journal of Pediatrics 1993;122:532-7. [DOI: 10.1016/s0022-3476(05)83531-0] [Cited by in Crossref: 71] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
54 Rowe PC, Orrbine E, Ogborn M, Wells GA, Winther W, Lior H, Manuel D, Mclaine PN. Epidemic Escherichia coli O157:H7 gastroenteritis and hemolytic-uremic syndrome in a Canadian Inuit community: Intestinal illness in family members as a risk factor. The Journal of Pediatrics 1994;124:21-6. [DOI: 10.1016/s0022-3476(94)70249-7] [Cited by in Crossref: 35] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
55 Schlieper A, Rowe PC, Orrbine E, Zoubek M, Clark W, Wolfish N, McLaine PN. Sequelae of haemolytic uraemic syndrome. Arch Dis Child 1992;67:930-4. [PMID: 1519959 DOI: 10.1136/adc.67.7.930] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
56 Adams N, Byrne L, Rose T, Adak B, Jenkins C, Charlett A, Violato M, O'Brien S, Whitehead M, Barr B, Taylor-Robinson D, Hawker J. Sociodemographic and clinical risk factors for paediatric typical haemolytic uraemic syndrome: retrospective cohort study. BMJ Paediatr Open 2019;3:e000465. [PMID: 31909217 DOI: 10.1136/bmjpo-2019-000465] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
57 Kleanthous H, Smith HR, Scotland SM, Gross RJ, Rowe B, Taylor CM, Milford DV. Haemolytic uraemic syndromes in the British Isles, 1985-8: association with verocytotoxin producing Escherichia coli. Part 2: Microbiological aspects. Arch Dis Child 1990;65:722-7. [PMID: 2201262 DOI: 10.1136/adc.65.7.722] [Cited by in Crossref: 140] [Cited by in F6Publishing: 140] [Article Influence: 4.4] [Reference Citation Analysis]
58 Brigotti M. The interactions of human neutrophils with shiga toxins and related plant toxins: danger or safety? Toxins (Basel) 2012;4:157-90. [PMID: 22741061 DOI: 10.3390/toxins4030157] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
59 Chart H, Rowe B. Serological identification of infection by Vero cytotoxin producing Escherichia coli in patients with haemolytic uraemic syndrome. Serodiagnosis and Immunotherapy in Infectious Disease 1990;4:413-8. [DOI: 10.1016/0888-0786(90)90053-q] [Cited by in Crossref: 17] [Article Influence: 0.5] [Reference Citation Analysis]
60 Cobeñas CJ, Bresso PS, Lombardi LL, Amoreo OR, Ruscasso JD, Spizzirri AP, Del C Suarez Â, Zalba JH, Rahman RC, Risso P. Relationship between red blood cell transfusion requirements and severity of renal disease during the acute stage of hemolytic uremic syndrome. Pediatr Nephrol 2015;30:2115-9. [PMID: 26141929 DOI: 10.1007/s00467-015-3147-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
61 Nakajima H, Kiyokawa N, Katagiri YU, Taguchi T, Suzuki T, Sekino T, Mimori K, Ebata T, Saito M, Nakao H, Takeda T, Fujimoto J. Kinetic Analysis of Binding between Shiga Toxin and Receptor Glycolipid Gb3Cer by Surface Plasmon Resonance. Journal of Biological Chemistry 2001;276:42915-22. [DOI: 10.1074/jbc.m106015200] [Cited by in Crossref: 98] [Cited by in F6Publishing: 45] [Article Influence: 4.7] [Reference Citation Analysis]
62 Challa S, Tzipori S, Sheoran A. Selective Evolution of Ligands by Exponential Enrichment to Identify RNA Aptamers against Shiga Toxins. J Nucleic Acids 2014;2014:214929. [PMID: 24839553 DOI: 10.1155/2014/214929] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
63 Allford SL, Hunt BJ, Rose P, Machin SJ; Haemostasis and Thrombosis Task Force, British Committee for Standards in Haematology. Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias. Br J Haematol. 2003;120:556-573. [PMID: 12588343 DOI: 10.1046/j.1365-2141.2003.04049.x] [Cited by in Crossref: 264] [Cited by in F6Publishing: 187] [Article Influence: 13.9] [Reference Citation Analysis]
64 Adams NL, Byrne L, Smith GA, Elson R, Harris JP, Salmon R, Smith R, O'Brien SJ, Adak GK, Jenkins C. Shiga Toxin-Producing Escherichia coli O157, England and Wales, 1983-2012. Emerg Infect Dis 2016;22:590-7. [PMID: 26982243 DOI: 10.3201/eid2204.151485] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 7.0] [Reference Citation Analysis]
65 Cloarec S, Deschênes G, Besson-leaud M, Casenave C, Gambert C, Guyot C, Hermouet Y, Romanet P, Roy C, Benoit S, Nivet H. Épidémiologie du syndrome hémolytique et urémique aigu postdiarrhéique de l'enfant dans quatre départements français. Archives de Pédiatrie 1996;3:1209-14. [DOI: 10.1016/s0929-693x(97)85930-1] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
66 Siebels M, Andrassy K, Waldherr R, Ritz E. Hemolytic uremic syndrome complicating postinfectious glomerulonephritis in the adult. American Journal of Kidney Diseases 1995;25:336-9. [DOI: 10.1016/0272-6386(95)90017-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
67 Gianviti A, Rosmini F, Caprioli A, Corona R, Matteucci MC, Principato F, Luzzi I, Rizzoni G; Italian HUS Study Group. Haemolytic-uraemic syndrome in childhood: surveillance and case-control studies in Italy. Pediatr Nephrol 1994;8:705-9. [DOI: 10.1007/bf00869095] [Cited by in Crossref: 27] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
68 Chart H, Rowe B. Improved detection of infection by Escherichia coli O157 in patients with haemolytic uraemic syndrome by means of IgA antibodies to lipopolysaccharide. Journal of Infection 1992;24:257-61. [DOI: 10.1016/s0163-4453(05)80030-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
69 Ong J, Zhe L, Robins-Browne R, Gapes M, O'Loughlin EV. Prevalence of verocytotoxigenic Escherichia coli serotype O157:H7 in children with diarrhoea attending a Sydney hospital. J Paediatr Child Health 1993;29:185-7. [PMID: 8517999 DOI: 10.1111/j.1440-1754.1993.tb00483.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
70 Harrison LM, Gaines DW, Babu US, Balan KV, Reimschuessel R, Do AB, Pereira MR, Bigley EC 3rd, Ferguson M, Mehta A, Williams KM. Diet-induced obesity precipitates kidney dysfunction and alters inflammatory mediators in mice treated with Shiga Toxin 2. Microb Pathog 2018;123:250-8. [PMID: 30016681 DOI: 10.1016/j.micpath.2018.07.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
71 Taylor CM, Milford DV, White RH. A plea for standardized terminology within the haemolytic uraemic syndromes. Pediatr Nephrol 1991;5:97. [PMID: 2025550 DOI: 10.1007/BF00852859] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
72 Pearce MC, Jenkins C, Vali L, Smith AW, Knight HI, Cheasty T, Smith HR, Gunn GJ, Woolhouse ME, Amyes SG, Frankel G. Temporal shedding patterns and virulence factors of Escherichia coli serogroups O26, O103, O111, O145, and O157 in a cohort of beef calves and their dams. Appl Environ Microbiol 2004;70:1708-16. [PMID: 15006796 DOI: 10.1128/AEM.70.3.1708-1716.2004] [Cited by in Crossref: 65] [Cited by in F6Publishing: 24] [Article Influence: 3.6] [Reference Citation Analysis]
73 Lopez EL, Devoto S, Fayad A, Canepa C, Morrow AL, Cleary TG. Association between severity of gastrointestinal prodrome and long-term prognosis in classic hemolytic-uremic syndrome. The Journal of Pediatrics 1992;120:210-5. [DOI: 10.1016/s0022-3476(05)80429-9] [Cited by in Crossref: 31] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
74 Proulx F, Turgeon JP, Delage G, Lior H, Lafleur L, Chicoine L. Immune response to verotoxin 1 and 2 in children with Escherichia coli O157:H7 hemorrhagic colitis and classic hemolytic uremic syndrome. Can J Infect Dis 1995;6:136-40. [PMID: 22514385 DOI: 10.1155/1995/825478] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
75 Tzipori S, Sheoran A, Akiyoshi D, Donohue-Rolfe A, Trachtman H. Antibody therapy in the management of shiga toxin-induced hemolytic uremic syndrome. Clin Microbiol Rev 2004;17:926-41, table of contents. [PMID: 15489355 DOI: 10.1128/CMR.17.4.926-941.2004] [Cited by in Crossref: 84] [Cited by in F6Publishing: 43] [Article Influence: 4.9] [Reference Citation Analysis]
76 Williams JM, Lea N, Lord J, Roberts LM, Milford DV, Taylor C. Comparison of ribosome-inactivating proteins in the induction of apoptosis. Toxicology Letters 1997;91:121-7. [DOI: 10.1016/s0378-4274(97)03879-4] [Cited by in Crossref: 61] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
77 Holm LP, Hawkins I, Robin C, Newton RJ, Jepson R, Stanzani G, McMahon LA, Pesavento P, Carr T, Cogan T, Couto CG, Cianciolo R, Walker DJ. Cutaneous and renal glomerular vasculopathy as a cause of acute kidney injury in dogs in the UK. Vet Rec 2015;176:384. [PMID: 25802439 DOI: 10.1136/vr.102892] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
78 Schmitt CK, Mckee ML, O'brien AD. Two copies of Shiga-like toxin II-related genes common in enterohemorrhagic Escherichia coli strains are responsible for the antigenic heterogeneity of the O157:H- strain E32511. Infect Immun 1991;59:1065-73. [DOI: 10.1128/iai.59.3.1065-1073.1991] [Cited by in Crossref: 185] [Cited by in F6Publishing: 104] [Article Influence: 6.0] [Reference Citation Analysis]
79 Cameron C, Gracey M, Penman AG. Haemolytic-uraemic syndrome in Western Australia, 1980 to 1994. Australian and New Zealand Journal of Public Health 1996;20:462-6. [DOI: 10.1111/j.1467-842x.1996.tb01622.x] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
80 Sheoran AS, Chapman-Bonofiglio S, Harvey BR, Mukherjee J, Georgiou G, Donohue-Rolfe A, Tzipori S. Human antibody against shiga toxin 2 administered to piglets after the onset of diarrhea due to Escherichia coli O157:H7 prevents fatal systemic complications. Infect Immun 2005;73:4607-13. [PMID: 16040972 DOI: 10.1128/IAI.73.8.4607-4613.2005] [Cited by in Crossref: 51] [Cited by in F6Publishing: 37] [Article Influence: 3.0] [Reference Citation Analysis]
81 Milford DV, White RH, Taylor CM. Prognostic significance of proteinuria one year after onset of diarrhea-associated hemolytic-uremic syndrome. J Pediatr 1991;118:191-4. [PMID: 1822077 DOI: 10.1016/s0022-3476(05)80481-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
82 George JN, Gilcher RO, Smith JW, Chandler L, Duvall D, Ellis C. Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: Diagnosis and management. J Clin Apheresis 1998;13:120-5. [DOI: 10.1002/(sici)1098-1101(1998)13:3<120::aid-jca5>3.0.co;2-e] [Cited by in Crossref: 37] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
83 Yamada S, Matsushita S, Kai A, Sasaki M, Tsuji A, Kanemitsu T, Yamashita N, Anzai E, Kudoh Y. Detection of verocytotoxin from stool and serological testing of patients with diarrhea caused by Escherichia coli O157 : H7. Microbiol Immunol 1993;37:111-8. [PMID: 8502176 DOI: 10.1111/j.1348-0421.1993.tb03187.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 0.5] [Reference Citation Analysis]
84 Sheoran AS, Chapman S, Singh P, Donohue-Rolfe A, Tzipori S. Stx2-specific human monoclonal antibodies protect mice against lethal infection with Escherichia coli expressing Stx2 variants. Infect Immun 2003;71:3125-30. [PMID: 12761090 DOI: 10.1128/IAI.71.6.3125-3130.2003] [Cited by in Crossref: 40] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
85 Sheoran AS, Dmitriev IP, Kashentseva EA, Cohen O, Mukherjee J, Debatis M, Shearer J, Tremblay JM, Beamer G, Curiel DT, Shoemaker CB, Tzipori S. Adenovirus vector expressing Stx1/Stx2-neutralizing agent protects piglets infected with Escherichia coli O157:H7 against fatal systemic intoxication. Infect Immun 2015;83:286-91. [PMID: 25368111 DOI: 10.1128/IAI.02360-14] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
86 Fitzpatrick MM, Shah V, Trompeter RS, Dillon MJ, Barratt TM. Interleukin-8 and polymorphoneutrophil leucocyte activation in hemolytic uremic syndrome of childhood. Kidney Int 1992;42:951-6. [PMID: 1453586 DOI: 10.1038/ki.1992.372] [Cited by in Crossref: 88] [Cited by in F6Publishing: 82] [Article Influence: 3.0] [Reference Citation Analysis]
87 Zimmermann H, Desgrandchamps D, Schubiger G. The Swiss Paediatric Surveillance Unit (SPSU). Soz Praventivmed 1995;40:392-5. [PMID: 8578881 DOI: 10.1007/BF01325425] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
88 Gracey M. Diarrhea and Malnutrition: A Challenge for Pediatricians: . Journal of Pediatric Gastroenterology & Nutrition 1996;22:6-16. [DOI: 10.1097/00005176-199601000-00004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
89 Kemper MJ. Outbreak of hemolytic uremic syndrome caused by E. coli O104:H4 in Germany: a pediatric perspective. Pediatr Nephrol 2012;27:161-4. [PMID: 22160440 DOI: 10.1007/s00467-011-2067-7] [Cited by in Crossref: 35] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
90 Fitzpatrick M. Haemolytic uraemic syndrome and E coli O157. BMJ 1999;318:684-5. [PMID: 10073994 DOI: 10.1136/bmj.318.7185.684] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
91 Loos S, Ahlenstiel T, Kranz B, Staude H, Pape L, Härtel C, Vester U, Buchtala L, Benz K, Hoppe B, Beringer O, Krause M, Müller D, Pohl M, Lemke J, Hillebrand G, Kreuzer M, König J, Wigger M, Konrad M, Haffner D, Oh J, Kemper MJ. An outbreak of Shiga toxin-producing Escherichia coli O104:H4 hemolytic uremic syndrome in Germany: presentation and short-term outcome in children. Clin Infect Dis 2012;55:753-9. [PMID: 22670043 DOI: 10.1093/cid/cis531] [Cited by in Crossref: 100] [Cited by in F6Publishing: 79] [Article Influence: 10.0] [Reference Citation Analysis]
92 Loirat C, Frémeaux-Bacchi V. Atypical hemolytic uremic syndrome. Orphanet J Rare Dis 2011;6:60. [PMID: 21902819 DOI: 10.1186/1750-1172-6-60] [Cited by in Crossref: 375] [Cited by in F6Publishing: 304] [Article Influence: 34.1] [Reference Citation Analysis]
93 Jeong KI, Tzipori S, Sheoran AS. Shiga toxin 2-specific but not shiga toxin 1-specific human monoclonal antibody protects piglets challenged with enterohemorrhagic Escherichia coli producing shiga toxin 1 and shiga toxin 2. J Infect Dis 2010;201:1081-3. [PMID: 20196656 DOI: 10.1086/651198] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
94 Yamada S, Kai A, Kudoh Y. Serodiagnosis by passive hemagglutination test and verotoxin enzyme-linked immunosorbent assay of toxin-producing Escherichia coli infections in patients with hemolytic-uremic syndrome. J Clin Microbiol 1994;32:955-9. [DOI: 10.1128/jcm.32.4.955-959.1994] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
95 Chart H, Said B, Stokes N, Rowe B. Heterogeneity in expression of lipopolysaccharides by strains of Escherichia coli O157. Journal of Infection 1993;27:237-41. [DOI: 10.1016/0163-4453(93)91952-l] [Cited by in Crossref: 16] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
96 Michael M, Elliott EJ, Craig JC, Ridley G, Hodson EM. Interventions for Hemolytic Uremic Syndrome and Thrombotic Thrombocytopenic Purpura: A Systematic Review of Randomized Controlled Trials. American Journal of Kidney Diseases 2009;53:259-72. [DOI: 10.1053/j.ajkd.2008.07.038] [Cited by in Crossref: 81] [Cited by in F6Publishing: 57] [Article Influence: 6.2] [Reference Citation Analysis]
97 Rahman RC, Cobeñas CJ, Drut R, Amoreo OR, Ruscasso JD, Spizzirri AP, Suarez Adel C, Zalba JH, Ferrari C, Gatti MC. Hemorrhagic colitis in postdiarrheal hemolytic uremic syndrome: retrospective analysis of 54 children. Pediatr Nephrol 2012;27:229-33. [PMID: 21809003 DOI: 10.1007/s00467-011-1973-z] [Cited by in Crossref: 33] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
98 Winwood PJ, Iredale JP, Williamson PJ, Lesna M, Loehry CA. Thrombotic thrombocytopenic purpura mimicking acute small bowel Crohn's disease. Gut 1992;33:857-9. [PMID: 1624173 DOI: 10.1136/gut.33.6.857] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
99 Rowe PC, Orrbine E, Lior H, Wells GA, McLaine PN. A prospective study of exposure to verotoxin-producing Escherichia coli among Canadian children with haemolytic uraemic syndrome. The CPKDRC co-investigators. Epidemiol Infect 1993;110:1-7. [PMID: 8432313 DOI: 10.1017/s0950268800050615] [Cited by in Crossref: 39] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
100 Siegler RL. The Hemolytic Uremic Syndrome. Pediatric Clinics of North America 1995;42:1505-29. [DOI: 10.1016/s0031-3955(16)40096-9] [Cited by in Crossref: 103] [Cited by in F6Publishing: 30] [Article Influence: 3.8] [Reference Citation Analysis]
101 de La Hunt MN, Rangecroft L, Morris KP, Coulthard MG. Oesophageal and severe gut involvement in the haemolytic uraemic syndrome. British Journal of Surgery 1991;78:1469-72. [DOI: 10.1002/bjs.1800781220] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
102 Liu Y, Wang S, Li T, Wang Q, Tu W, Cai K, Hou X, Tian R, Gao X, Liu H, Xiao L, Shi J, Cheng Y, Li J, Wang H. Shiga toxin type 2 (Stx2), a potential agent of bioterrorism, has a short distribution and a long elimination half-life, and induces kidney and thymus lesions in rats. Arch Toxicol 2011;85:1133-40. [DOI: 10.1007/s00204-010-0639-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
103 Rodríguez-Pintó I, Espinosa G, Cervera R. Catastrophic APS in the context of other thrombotic microangiopathies. Curr Rheumatol Rep 2015;17:482. [PMID: 25604575 DOI: 10.1007/s11926-014-0482-z] [Cited by in Crossref: 35] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
104 Kitova EN, Kitov PI, Paszkiewicz E, Kim J, Mulvey GL, Armstrong GD, Bundle DR, Klassen JS. Affinities of Shiga toxins 1 and 2 for univalent and oligovalent Pk-trisaccharide analogs measured by electrospray ionization mass spectrometry. Glycobiology 2007;17:1127-37. [PMID: 17686801 DOI: 10.1093/glycob/cwm081] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 2.5] [Reference Citation Analysis]
105 Bitzan M, Ludwig K, Klemt M, König H, Büren J, Müller-Wiefel DE. The role of Escherichia coli O 157 infections in the classical (enteropathic) haemolytic uraemic syndrome: results of a Central European, multicentre study. Epidemiol Infect 1993;110:183-96. [PMID: 8472763 DOI: 10.1017/s0950268800068102] [Cited by in Crossref: 80] [Cited by in F6Publishing: 29] [Article Influence: 2.8] [Reference Citation Analysis]
106 Chart H, van der Kar NC, Tolboom JJ, Monnens LM, Rowe B. Serological detection of verocytotoxin-producing Escherichia coli in patients with haemolytic uraemic syndrome in western Europe. Eur J Clin Microbiol Infect Dis 1993;12:707-9. [PMID: 7694851 DOI: 10.1007/BF02009386] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
107 Knowles RL, Friend H, Lynn R, Mitchell S, Michie C, Ihekweazu C; British Paediatric Surveillance Unit (BPSU). Surveillance of rare diseases: a public health evaluation of the British Paediatric Surveillance Unit. J Public Health (Oxf) 2012;34:279-86. [PMID: 21852323 DOI: 10.1093/pubmed/fdr058] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
108 Robson WL. Haemolytic uraemic syndrome. Paediatr Drugs 2000;2:243-52. [PMID: 10946413 DOI: 10.2165/00128072-200002040-00001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
109 Douglas AS, Kurien A. Seasonality and other epidemiological features of haemolytic uraemic syndrome and E. coli O157 isolates in Scotland. Scott Med J 1997;42:166-71. [PMID: 9507594 DOI: 10.1177/003693309704200603] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
110 Tozzi AE, Caprioli A, Minelli F, Gianviti A, De Petris L, Edefonti A, Montini G, Ferretti A, De Palo T, Gaido M, Rizzoni G; Hemolytic Uremic Syndrome Study Group. Shiga toxin-producing Escherichia coli infections associated with hemolytic uremic syndrome, Italy, 1988-2000. Emerg Infect Dis 2003;9:106-8. [PMID: 12533290 DOI: 10.3201/eid0901.020266] [Cited by in Crossref: 136] [Cited by in F6Publishing: 128] [Article Influence: 7.2] [Reference Citation Analysis]